Cardiovascular Outcomes Research Laboratories (CORELAB), UCLA Center for Health Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Ann Surg Oncol. 2023 May;30(5):3002-3010. doi: 10.1245/s10434-022-13032-8. Epub 2023 Jan 2.
With a large body of literature demonstrating positive volume-outcome relationships for most major operations, minimum volume requirements have been suggested for concentration of cases to high-volume centers (HVCs). However, data are limited regarding disparities in access to these hospitals for pancreatectomy patients.
The 2005-2018 National Inpatient Sample (NIS) was queried for all elective adult hospitalizations for pancreatectomy. Hospitals performing more than 20 annual cases were classified as HVCs. Mixed-multivariable regression models were developed to characterize the impact of demographic factors and case volume on outcomes of interest.
Of an estimated 127,527 hospitalizations, 79.8% occurred at HVCs. Patients at these centers were more frequently white (79.0 vs 70.8%; p < 0.001), privately insured (39.4 vs 34.2%; p < 0.001), and within the highest income quartile (30.5 vs 25.0%; p < 0.001). Adjusted analysis showed that operations performed at HVCs were associated with reduced odds of in-hospital mortality (adjusted odds ratio [AOR], 0.43; 95% confidence interval [CI], 0.34-0.55), increased odds of discharge to home (AOR, 1.17; 95% CI, 1.04-1.30), shorter hospital stay (β, -0.81 days; 95% CI, -1.2 to -0.40 days), but similar costs. Patients who were female (AOR, 0.88; 95% CI, 0.79-0.98), non-white (black: AOR, 0.66; 95% CI, 0.59-0.75; Hispanic: AOR, 0.56; 95% CI, 0.47-0.66; reference, white), insured by Medicaid (AOR, 0.63; 95% CI, 0.56-0.72; reference, private), and within the lowest income quartile (AOR, 0.73; 95% CI, 0.59-0.90; reference, highest) had decreased odds of treatment at an HVC.
For those undergoing pancreatectomies, HVCs realize superior clinical outcomes but treat lower proportions of female, non-white, and Medicaid populations. These findings may have implications for improving access to high-quality centers.
大量文献表明,大多数主要手术的数量-结局关系呈正相关,因此建议将病例数量下限设定在高容量中心(HVC)以集中病例。然而,有关胰腺切除术患者获得这些医院治疗机会的差异的数据有限。
2005 年至 2018 年的国家住院患者样本(NIS)被检索用于所有择期成人胰腺切除术的住院治疗。每年进行超过 20 例手术的医院被归类为 HVC。采用混合多变量回归模型来描述人口统计学因素和病例数量对研究结果的影响。
在估计的 127527 例住院治疗中,79.8%发生在 HVC。这些中心的患者更常见为白人(79.0%比 70.8%;p<0.001),私人保险(39.4%比 34.2%;p<0.001),且收入处于最高四分位数(30.5%比 25.0%;p<0.001)。调整分析显示,在 HVC 进行的手术与降低院内死亡率的几率相关(调整后的优势比 [AOR],0.43;95%置信区间 [CI],0.34-0.55),出院回家的几率增加(AOR,1.17;95%CI,1.04-1.30),住院时间缩短(β,-0.81 天;95%CI,-1.20 至-0.40 天),但治疗费用相似。女性(AOR,0.88;95%CI,0.79-0.98)、非白人(黑人:AOR,0.66;95%CI,0.59-0.75;西班牙裔:AOR,0.56;95%CI,0.47-0.66;参考,白人)、医疗补助保险(AOR,0.63;95%CI,0.56-0.72;参考,私人)和收入最低四分位数(AOR,0.73;95%CI,0.59-0.90;参考,最高)的患者在 HVC 接受治疗的几率较低。
对于接受胰腺切除术的患者,HVC 实现了更好的临床结局,但治疗的女性、非白人以及医疗补助保险患者比例较低。这些发现可能对提高获得高质量中心治疗的机会具有重要意义。